Tranexamic Acid in Chinese Elderly Patients With Intertrochanteric Fracture RCT
Status:
Active, not recruiting
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
Hip fracture posed a major challenge to the health care system, with the one-year mortality
of hip fracture reported as being approximately 20%. Perioperative haemoglobin level was
associated with functional level of the patient and even mortality.
Different methods for administration of tranexamic acid had been described. It was well
established that systemic administration of tranexamic acid could reduce perioperative blood
loss and transfusion rate. Topical administration had been shown to decrease blood loss and
transfusion rate.
The objective of our study is to investigate the hypothesis that tranexamic acid will reduce
blood loss and transfusion rate in elderly patients undergoing hip fracture surgery.